Oncolytics Biotech (ONCY) Shares Issued (2010 - 2011)

Oncolytics Biotech's (ONCY) quarterly Shares Issued came in at $177.2 million in Q2 2011, little changed on a QoQ basis from $177.1 million in Q1 2011.

Oncolytics Biotech (ONCY) Shares Issued (2010 - 2011) Analysis & Trends

Oncolytics Biotech (ONCY) has 2 years of Shares Issued data on file, last reported at $177.2 million in Q2 2011.

  • On a quarterly basis, Shares Issued changed N/A year-over-year to $177.2 million in Q2 2011; TTM through Jun 2011 was $177.2 million, a N/A change from a year earlier, with the FY2010 full-year figure at $155.4 million, changed N/A from the prior year.
  • Shares Issued for Q2 2011 stood at $177.2 million, roughly flat from $177.1 million in the prior quarter.
  • Over the last five years, Shares Issued for ONCY reached as high as $177.2 million in Q2 2011 and fell as low as $155.4 million in Q4 2010.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Issued (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 19.44 Mn
10 Oncolytics Biotech 372.40 Mn 372.40 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2011 177.18 Mn
Jun 30, 2011 177.18 Mn
Mar 31, 2011 177.15 Mn
Mar 31, 2011 177.15 Mn
Dec 31, 2010 155.44 Mn
Dec 31, 2010 155.44 Mn